Product
Drospirenone
6 clinical trials
5 indications
Indication
ObesityIndication
Healthy FemaleIndication
ContraceptionIndication
Change in Bone Mineral DensityIndication
AdenomyosisClinical trial
A Phase 1 Study to Investigate the Effect of LY3437943 on the Pharmacokinetics of the Combined Oral Contraceptive Ethinyl Estradiol and Drospirenone in Female ParticipantsStatus: Active (not recruiting), Estimated PCD: 2024-07-04
Clinical trial
An Open-label, Non-randomized Study to Investigate the Effects of Twice-Daily Milvexian Administration on the Pharmacokinetics of Single Doses of Midazolam, Ethinylestradiol and Drospirenone in Healthy Adult FemalesStatus: Completed, Estimated PCD: 2023-07-20
Clinical trial
A Phase 3, Multi-Center, Non-Comparative Study to Evaluate the Contraceptive Efficacy, Safety, and Tolerability of LPRI-CF113 Administered Orally for 13 Medication CyclesStatus: Active (not recruiting), Estimated PCD: 2024-05-01
Clinical trial
Pharmacokinetics of Drospirenone Only Pills in Obese Thai Women: A Pre- and Post-Bariatric Surgery StudyStatus: Not yet recruiting, Estimated PCD: 2025-04-01
Clinical trial
Drospirenone Only Pills and Cervical Mucus Changes in Obese Thai Women: A Pre- and Post-Bariatric Surgery StudyStatus: Not yet recruiting, Estimated PCD: 2025-04-01
Clinical trial
Evaluation of the Efficacy and Safety of Drospirenone in the Treatment of AdenomyosisStatus: Not yet recruiting, Estimated PCD: 2024-06-01